HealthChain Project: CardiacSense Revolutionizing Healthcare Monitoring Across Europe
March 26, 2024
Wherever you go,
bring your physician along
Hundreds of millions of people worldwide suffer from hypertension, yet only a few have it under control. These people need constant monitoring.
Stay informed with our latest news
The Chip
SOM small-sized system for flexibility of use
Clinical CardiacSense Results
VS.
FDA Threshold
From Average of 24 participants
Sensitivity
99.1%
96%
or higher
FDR
False Detection Rate
0.6%
2%
or lower
Correlation coefficient
97.8%
90%
or higher
Regression line slope
1.00
1± 0.02
PPV
Positive Predictive Value
99.4%
80%
or higher
Bland-Altman 95% limits of agreement
27.5ms
Average
(±tolerance) ±
1.96*SD: 0 (±5) ± 100
Clinical studies demonstrated the accuracy of the CardiacSense algorithm: 99% sensitivity and 99% specificity in distinguishing atrial fibrillation (AF) from sinus rhythm.
Read more about our clinical trials that showed the CardiacSense watch to be as precise as ECG monitoring.